Se-Aspirin is primarily researched for its potential in cancer prevention and treatment. Its unique combination of selenium and acetylsalicylic acid enhances its antioxidant properties, which may help in reducing oxidative stress linked to cancer development. Studies suggest it could inhibit the growth of cancer cells more effectively than traditional aspirin, making it a promising candidate for chemopreventive strategies. Additionally, Se-Aspirin is being explored for its anti-inflammatory effects, which could be beneficial in managing chronic inflammatory diseases. Its dual action of targeting inflammation and oxidative damage positions it as a versatile compound in therapeutic applications.